- mail us help@24marketresearch.com
- Int'l 1(332) 2424 294 (Int'l)
TOP CATEGORY: Chemicals & Materials | Life Sciences | Banking & Finance | ICT Media
The Asia Pacific Liquid Runway Deicer market size was valued at US$ 89.4 million in 2024 and is projected to reach US$ 116.2 million by 2030, at a CAGR of 4.5% during the forecast period 2024-2030.
Liquid runway deicers are chemical formulations used to prevent or remove ice and snow accumulation on airport runways, taxiways, and aprons, ensuring safe aircraft operations in cold weather conditions.
The Asia Pacific liquid runway deicer market is experiencing moderate growth, driven by expanding air travel and increasing focus on aviation safety. China accounts for 35% of the market, followed by Japan at 25% and South Korea at 20%. In 2023, potassium acetate-based deicers dominated with a 60% market share, followed by propylene glycol-based products at 30%. The market saw an 8% increase in demand for environmentally friendly formulations with lower corrosion potential. Key players include Clariant AG (Switzerland) and Cryotech Deicing Technology (USA), collectively holding a 45% market share in the region. The industry is investing in advanced application technologies, with a 15% increase in adoption of precision spraying systems in 2023. Challenges include environmental concerns and regulatory pressures, leading to a 10% focus on developing bio-based deicer alternatives. The trend towards preventive deicing has driven a 12% growth in demand for anti-icing liquids. The market is benefiting from the expansion of airport infrastructure in emerging economies, with a 20% increase in new airport construction projects incorporating modern deicing facilities.
Report Includes
This report is an essential reference for who looks for detailed information on Asia Pacific Tranexamic Acid . The report covers data on Asia Pacific markets including historical and future trends for supply, market size, prices, trading, competition and value chain as well as Asia Pacific major vendors¡¯ information. In addition to the data part, the report also provides overview of Tranexamic Acid , including classification, application, manufacturing technology, industry chain analysis and latest market dynamics. Finally, a customization report in order to meet user's requirements is also available.
This report aims to provide a comprehensive presentation of the Asia Pacific Tranexamic Acid , with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Tranexamic Acid . This report contains market size and forecasts of Tranexamic Acid in Asia Pacific, including the following market information:
We surveyed the Tranexamic Acid manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
• China
• India
• Japan
• South Korea
• Australia
• Thailand
• Indonesia
• USP25
• BP2000
• Other
• Trauma
• Craniocerebral Trauma
• Menorrhagia
• Postpartum Hemorrhage
• Surgery
• Other Treatment
• Whitening Cosmetics
• CSL Limited
• Shanghai Fosun Pharmaceutical (Group) Co., Ltd.
• JK Sucralose Inc.
• Yunnan Baiyao Group Co., Ltd.
• OlainFarm
• Hisun Pharmaceuticals
• Pfizer Asia Pacific Pte. Ltd.
• Wanbang Biopharmaceuticals
• Sun Pharmaceutical Industries Ltd.
• Torrent Pharmaceuticals Ltd.
Including or excluding key companies relevant to your analysis.
The report also provides analysis of leading market participants including:
• Key companies Tranexamic Acid revenues in Asia Pacific market, 2019-2024 (Estimated), ($ millions)
• Key companies Tranexamic Acid revenues share in Asia Pacific market, 2023 (%)
• Key companies Tranexamic Acid sales in Asia Pacific market, 2019-2024 (Estimated),
• Key companies Tranexamic Acid sales share in Asia Pacific market, 2023 (%)
Key Points of this Report:
• The depth industry chain includes analysis value chain analysis, porter five forces model analysis and cost structure analysis
• The report covers Asia Pacific and country-wise market of Tranexamic Acid
• It describes present situation, historical background and future forecast
• Comprehensive data showing Tranexamic Acid capacities, production, consumption, trade statistics, and prices in the recent years are provided
• The report indicates a wealth of information on Tranexamic Acid manufacturers
• Tranexamic Acid forecast for next five years, including market volumes and prices is also provided
• Raw Material Supply and Downstream Consumer Information is also included
• Any other user's requirements which is feasible for us
Reasons to Purchase this Report:
• Analyzing the outlook of the market with the recent trends and SWOT analysis
• Market dynamics scenario, along with growth opportunities of the market in the years to come
• Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and non-economic aspects
• Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market.
• Market value (USD Million) and volume (Units Million) data for each segment and sub-segment
• Distribution Channel sales Analysis by Value
• Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the past five years
• Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players
• 1-year analyst support, along with the data support in excel format.
1.1 Product Overview and Scope of Tranexamic Acid
1.2.1 Asia Pacific Market Size YoY Growth Rate Analysis by Type: 2023 VS 2030
1.2.2 USP25
1.2.3 BP2000
1.2.4 Other
1.3.1 Asia Pacific Market Size YoY Growth Rate Analysis by Application: 2023 VS 2030
1.3.2 Trauma
1.3.3 Craniocerebral Trauma
1.3.4 Menorrhagia
1.3.5 Postpartum Hemorrhage
1.3.6 Surgery
1.3.7 Other Treatment
1.3.8 Whitening Cosmetics
1.4 Asia Pacific Market Growth Prospects
1.4.1 Asia Pacific Revenue Estimates and Forecasts (2019-2030)
1.4.2 Asia Pacific Production Estimates and Forecasts (2019-2030)
2.1 Industry Trends
2.1.1 SWOT Analysis
2.1.2 PESTEL Analysis
2.1.3 Porter’s Five Forces Analysis
2.2 Potential Market and Growth Potential Analysis
3.1 Asia Pacific Production by Manufacturers (2019-2023)
3.2 Asia Pacific Revenue Market Share by Manufacturers (2019-2023)
3.3 Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Asia Pacific Average Price by Manufacturers (2019-2023)
3.5 Manufacturers Production Sites, Area Served, Product Type
3.6 Market Competitive Situation and Trends
3.6.1 Market Concentration Rate
3.6.2 Asia Pacific 5 and 10 Largest Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4.1 Asia Pacific Production
4.1.1 Asia Pacific Production YoY Growth Rate (2019-2023)
4.1.2 Asia Pacific Production, Revenue, Price and Gross Margin (2019-2024)
5.1 Asia Pacific
5.1.1 Asia Pacific Consumption by Country
5.1.2 Asia Pacific Sales, Consumption, Export, Import (2019-2023)
5.1.1 China
5.2.2 India
5.3.3 Japan
5.4.4 South Korea
5.5.5 Australia
5.6.6 Thailand
5.7.7 Indonesia
6.1 Asia Pacific Production Market Share by Type (2019-2024)
6.2 Asia Pacific Revenue Market Share by Type (2019-2024)
6.3 Asia Pacific Price by Type (2019-2024)
7.1 Asia Pacific Production Market Share by Application (2019-2024)
7.2 Asia Pacific Revenue Market Share by Application (2019-2024)
7.3 Asia Pacific Price by Application (2019-2024)
8.1 CSL Limited
8.1.1 CSL Limited Corporation Information
8.1.2 CSL Limited Product Portfolio
8.1.3 CSL Limited Production Capacity, Revenue, Price and Gross Margin (2019-2024)
8.1.4 CSL Limited Main Business and Markets Served
8.1.5 CSL Limited Recent Developments/Updates
8.2 Shanghai Fosun Pharmaceutical (Group) Co., Ltd.
8.2.1 Shanghai Fosun Pharmaceutical (Group) Co., Ltd. Corporation Information
8.2.2 Shanghai Fosun Pharmaceutical (Group) Co., Ltd. Product Portfolio
8.2.3 Shanghai Fosun Pharmaceutical (Group) Co., Ltd. Production Capacity, Revenue, Price and Gross Margin (2019-2024)
8.2.4 Shanghai Fosun Pharmaceutical (Group) Co., Ltd. Main Business and Markets Served
8.2.5 Shanghai Fosun Pharmaceutical (Group) Co., Ltd. Recent Developments/Updates
8.3 JK Sucralose Inc.
8.3.1 JK Sucralose Inc. Corporation Information
8.3.2 JK Sucralose Inc. Product Portfolio
8.3.3 JK Sucralose Inc. Production Capacity, Revenue, Price and Gross Margin (2019-2024)
8.3.4 JK Sucralose Inc. Main Business and Markets Served
8.3.5 JK Sucralose Inc. Recent Developments/Updates
8.4 Yunnan Baiyao Group Co., Ltd.
8.4.1 Yunnan Baiyao Group Co., Ltd. Corporation Information
8.4.2 Yunnan Baiyao Group Co., Ltd. Product Portfolio
8.4.3 Yunnan Baiyao Group Co., Ltd. Production Capacity, Revenue, Price and Gross Margin (2019-2024)
8.4.4 Yunnan Baiyao Group Co., Ltd. Main Business and Markets Served
8.4.5 Yunnan Baiyao Group Co., Ltd. Recent Developments/Updates
8.5 OlainFarm
8.5.1 OlainFarm Corporation Information
8.5.2 OlainFarm Product Portfolio
8.5.3 OlainFarm Production Capacity, Revenue, Price and Gross Margin (2019-2024)
8.5.4 OlainFarm Main Business and Markets Served
8.5.5 OlainFarm Recent Developments/Updates
8.6 Hisun Pharmaceuticals
8.6.1 Hisun Pharmaceuticals Corporation Information
8.6.2 Hisun Pharmaceuticals Product Portfolio
8.6.3 Hisun Pharmaceuticals Production Capacity, Revenue, Price and Gross Margin (2019-2024)
8.6.4 Hisun Pharmaceuticals Main Business and Markets Served
8.6.5 Hisun Pharmaceuticals Recent Developments/Updates
8.7 Pfizer Asia Pacific Pte. Ltd.
8.7.1 Pfizer Asia Pacific Pte. Ltd. Corporation Information
8.7.2 Pfizer Asia Pacific Pte. Ltd. Production Capacity, Revenue, Price and Gross Margin (2019-2024)
8.7.3 Pfizer Asia Pacific Pte. Ltd. Main Business and Markets Served
8.7.4 Pfizer Asia Pacific Pte. Ltd. Recent Developments/Updates
8.8 Wanbang Biopharmaceuticals
8.8.1 Wanbang Biopharmaceuticals Corporation Information
8.8.2 Wanbang Biopharmaceuticals Product Portfolio
8.8.3 Wanbang Biopharmaceuticals Production Capacity, Revenue, Price and Gross Margin (2019-2024)
8.8.4 Wanbang Biopharmaceuticals Main Business and Markets Served
8.8.5 Wanbang Biopharmaceuticals Recent Developments/Updates
8.9 Sun Pharmaceutical Industries Ltd.
8.9.1 Sun Pharmaceutical Industries Ltd. Corporation Information
8.9.2 Sun Pharmaceutical Industries Ltd. Product Portfolio
8.9.3 Sun Pharmaceutical Industries Ltd. Production Capacity, Revenue, Price and Gross Margin (2019-2024)
8.9.4 Sun Pharmaceutical Industries Ltd. Main Business and Markets Served
8.9.5 Sun Pharmaceutical Industries Ltd. Recent Developments/Updates
8.10 Torrent Pharmaceuticals Ltd.
8.10.1 Torrent Pharmaceuticals Ltd. Corporation Information
8.10.2 Torrent Pharmaceuticals Ltd. Product Portfolio
8.10.3 Torrent Pharmaceuticals Ltd. Production Capacity, Revenue, Price and Gross Margin (2019-2024)
8.10.4 Torrent Pharmaceuticals Ltd. Main Business and Markets Served
8.10.5 Torrent Pharmaceuticals Ltd. Recent Developments/Updates
9.1 Key Raw Materials Analysis
9.1.1 Key Raw Materials
9.1.2 Key Suppliers of Raw Materials
9.2 Proportion of Manufacturing Cost Structure
9.3 Manufacturing Process Analysis of Tranexamic Acid
9.4 Industrial Chain Analysis
10.1 Marketing Channel
10.2 Distributors List
10.3 Customers
11.1 Industry Trends
11.2 Market Drivers
11.3 Market Challenges
11.4 Market Restraints
12.1 Asia Pacific Production, Revenue Forecast (2024-2030)
13.1 Asia Pacific Forecasted Consumption of by Country
14.1 Asia Pacific Production, Revenue and Price Forecast by Type (2024-2030)
14.1.1 Asia Pacific Forecasted Production of by Type (2024-2030)
14.1.2 Asia Pacific Forecasted Revenue of by Type (2024-2030)
14.1.3 Asia Pacific Forecasted Price of by Type (2024-2030)
14.2 Asia Pacific Production, Revenue and Price Forecast by Application (2024-2030)
14.2.1 Asia Pacific Forecasted Production of by Application (2024-2030)
14.2.2 Asia Pacific Forecasted Revenue of by Application (2024-2030)
14.2.3 Asia Pacific Forecasted Price of by Application (2024-2030)
16.1 Methodology/Research Approach
16.1.1 Research Programs/Design
16.1.2 Market Size Estimation
16.1.3 Market Breakdown and Data Triangulation
16.2 Data Source
16.2.1 Secondary Sources
16.2.2 Primary Sources
16.3 Author List
16.4 Disclaimer
17.1 Note
17.2 Examples of Clients
Frequently Asked Questions ?
